Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-23-000264
Filing Date
2023-01-05
Accepted
2023-01-05 16:30:44
Documents
1
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-58086.html 3  
1 PRIMARY DOCUMENT marketforms-58086.xml 3 1718
  Complete submission text file 0001214659-23-000264.txt   3258
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XOMA CORPORATION 2200 POWELL STREET, SUITE 310 EMERYVILLE CA 94608
Business Address
Sitko Bradley (Reporting) CIK: 0001959809 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39801 | Film No.: 23511760